Protocol Ledger

NCT04435431 · Phase II · COMPLETED

A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

Interventional Phase II clinical trial protocol NCT04435431 sponsored by Integrative Research Laboratories in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-10-29 Enrollment: 155 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04435431
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)155 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04435431
Protocol FieldVerified Registry Value
NCT IdentifierNCT04435431
Consolidated Lead SponsorIntegrative Research Laboratories
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment155 participants (ACTUAL)
Registered Start Date2020-10-29
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI